Published on : Nov 03, 2017
Albany, New York, November 3, 2017: The global high-flow nasal cannula market is likely to grow at a robust CAGR to rake in over US$ 9 bn in revenues by 2025. The market will continue to be impacted by a number of macro- and micro-economic factors. These insights are according to a new research report added to the repository of Market Research Hub (MRH). The report titled “High-flow Nasal Cannula Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” offers detailed insights and analysis on the high-flow nasal cannula market during the forecast period.
The report begins with an executive summary which offers highlights and gist of the report. The succeeding sections involve information on the leading drivers, trends, opportunities, and restraints that the global high-flow nasal cannula industry players are facing currently. The qualitative information in the report, including the assessment on market dynamics offers readers detailed information on the key factors that are shaping the global high-flow nasal cannula market.
Increase in the prevalence of respiratory disorders and focus on developing innovative management and treatment procedures is likely to provide an impetus to the growth of the market during the forecast period. Increasing emphasis on boosting healthcare infrastructure in developing countries is also likely to augur well for the prospects of the global high-flow nasal cannula market during the forecast period.
On the basis of application, demand for high-flow nasal cannulas is highest in acute respiratory failure segment. The other key segment on the basis of disease indication includes chronic pulmonary disease. Applications in these end-uses is likely to provide an impetus to the growth of the global market during the forecast period.
North America, led by the U.S. remains a key market for high-flow nasal cannula market during the forecast period. According to the report, high awareness and focus among healthcare providers, combined with favorable reimbursement policies are likely to provide an impetus to the growth of the market during the forecast period. The North America high flow nasal cannula market is likely to grow at a CAGR of over 11% during the forecast period.
While Europe remains the other key market for high-flow nasal cannula, it is the market in Asia Pacific that is likely to grow at a high CAGR during the forecast period. Focus on improving treatment procedures combined with increasing investments by foreign players is likely to boost the market in Asia Pacific.
Some of the leading players in the global high nasal cannula market include ResMed, Inc., Teijin Pharma Limited, Smiths Medical, Hamilton Medical, Becton, Fisher & Paykel Healthcare Limited, TNI medical AG, Dickinson and Company, Flexicare Medical Limited, Salter Labs, MEK-ICS CO., LTD., Teleflex Incorporated, Vapotherm, Inc., and Great Group Medical Co., Ltd.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1359789
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com